(0.20%) 5 142.00 points
(0.20%) 38 518 points
(0.29%) 17 897 points
(-0.93%) $83.07
(1.56%) $1.953
(-0.34%) $2 339.20
(-1.33%) $27.17
(0.27%) $924.60
(-0.13%) $0.933
(-0.09%) $11.01
(-0.20%) $0.799
(0.86%) $92.66
0.00% HKD 0.265
Live Chart Being Loaded With Signals
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia...
Stats | |
---|---|
Tagesvolumen | 10 000.00 |
Durchschnittsvolumen | 395 016 |
Marktkapitalisierung | 569.76M |
EPS | HKD0 ( 2023-08-28 ) |
Last Dividend | HKD0.00260 ( 2023-06-29 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -26.50 |
ATR14 | HKD0 (0.00%) |
Tianda Pharmaceuticals Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Tianda Pharmaceuticals Finanzdaten
Annual | 2023 |
Umsatz: | HKD532.09M |
Bruttogewinn: | HKD255.53M (48.02 %) |
EPS: | HKD-0.0112 |
FY | 2023 |
Umsatz: | HKD532.09M |
Bruttogewinn: | HKD255.53M (48.02 %) |
EPS: | HKD-0.0112 |
FY | 2022 |
Umsatz: | HKD546.69M |
Bruttogewinn: | HKD251.52M (46.01 %) |
EPS: | HKD-0.0254 |
FY | 2022 |
Umsatz: | HKD509.96M |
Bruttogewinn: | HKD241.22M (47.30 %) |
EPS: | HKD-0.0101 |
Financial Reports:
No articles found.
Tianda Pharmaceuticals Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0112 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.00260 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00450 | 2010-07-23 |
Last Dividend | HKD0.00260 | 2023-06-29 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | HKD0.0530 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.23 | -- |
Div. Sustainability Score | 4.25 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 1.955 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3808.HK | Ex Dividend Junior | 2023-07-04 | Annually | 0 | 0.00% | |
1696.HK | Ex Dividend Junior | 2023-08-24 | Annually | 0 | 0.00% | |
0730.HK | Ex Dividend Junior | 2023-05-24 | Annually | 0 | 0.00% | |
2283.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
1270.HK | Ex Dividend Knight | 2023-05-16 | Annually | 0 | 0.00% | |
0323.HK | No Dividend Player | 2023-06-21 | Sporadic | 0 | 0.00% | |
6055.HK | Ex Dividend Knight | 2023-06-13 | Annually | 0 | 0.00% | |
1821.HK | Ex Dividend Junior | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
0856.HK | Ex Dividend Junior | 2023-05-31 | Annually | 0 | 0.00% | |
0010.HK | Ex Dividend Knight | 2023-09-12 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0454 | 1.500 | -0.908 | -1.362 | [0 - 0.5] |
returnOnAssetsTTM | -0.0263 | 1.200 | -0.878 | -1.053 | [0 - 0.3] |
returnOnEquityTTM | -0.0405 | 1.500 | -1.561 | -2.34 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.099 | 0.800 | 9.51 | 7.61 | [1 - 3] |
quickRatioTTM | 0.854 | 0.800 | 9.68 | 7.75 | [0.8 - 2.5] |
cashRatioTTM | 0.518 | 1.500 | 8.23 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.120 | -1.500 | 7.99 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -5.45 | 1.000 | -3.13 | -3.13 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.0241 | 2.00 | -0.00802 | -0.0160 | [0 - 30] |
freeCashFlowPerShareTTM | -0.0424 | 2.00 | -0.0212 | -0.0424 | [0 - 20] |
debtEquityRatioTTM | 0.187 | -1.500 | 9.25 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.480 | 1.000 | 5.33 | 5.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0545 | 1.000 | -3.09 | -3.09 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.468 | 1.000 | -3.71 | -3.71 | [0.2 - 2] |
assetTurnoverTTM | 0.580 | 0.800 | 9.47 | 7.57 | [0.5 - 2] |
Total Score | 4.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -23.59 | 1.000 | -2.48 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0405 | 2.50 | -1.003 | -2.34 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.0424 | 2.00 | -0.0141 | -0.0424 | [0 - 30] |
dividendYielPercentageTTM | 0.981 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.0241 | 2.00 | -0.00802 | -0.0160 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.156 | 1.500 | -2.30 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0972 | 1.000 | -4.93 | 0 | [0.1 - 0.5] |
Total Score | -0.341 |
Tianda Pharmaceuticals
Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.